Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer

Lung cancer (LC) represents the second most diagnosed tumor and the malignancy with the highest mortality rate. In recent years, tremendous progress has been made in the treatment of this tumor thanks to the discovery, testing, and clinical approval of novel therapeutic approaches. Firstly, targeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Leone, Gian Marco, Candido, Saverio, Lavoro, Alessandro, Vivarelli, Silvia, Gattuso, Giuseppe, Calina, Daniela, Libra, Massimo, Falzone, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142433/
https://www.ncbi.nlm.nih.gov/pubmed/37111737
http://dx.doi.org/10.3390/pharmaceutics15041252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142433/
https://www.ncbi.nlm.nih.gov/pubmed/37111737
http://dx.doi.org/10.3390/pharmaceutics15041252

Ejemplares similares